Iris Loew-friedrich
Executive Vice President Chief Medical Officer
Biopharmaceutical
UCB
Spain
Biography
Prof. Dr. med. Iris Loew-Friedrich is Executive Vice President and Chief Medical Officer, UCB. She provides strategic global leadership for project leadership, world-wide clinical development, medical affairs and global regulatory affairs for UCB’s portfolio of pipeline projects and products
Research Interest
Her mission is to lead UCB’s Development and Medical Practices and help develop patient solutions with proven superior and sustainable value for patients suffering from severe diseases. Dr. Loew-Friedrich also oversees UCB’s Patient Affairs function, which places a strategic focus on better understanding and improving the patient experience in currently underserved medical areas in immunological and neurological diseases.
